Jasper Therapeutics, Inc. (JSPR)

3d ago, source: Yahoo Finance

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...

Jasper Therapeutics, Inc. (JSPR) Is Up 24.77% in One Week: What You Should Know

1mon ago, source: Zacks.com on MSN

Below, we take a look at Jasper Therapeutics, Inc. (JSPR), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the ...

Here's Why Momentum in Jasper Therapeutics, Inc. (JSPR) Should Keep going

1mon ago, source: Hosted on MSN

There are several stocks that passed through the screen and Jasper Therapeutics, Inc. (JSPR) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.

Jasper Therapeutics Inc Ordinary Shares

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jasper Therapeutics (NASDAQ: JSPR)

7d ago, source: The Motley Fool

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of ...

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

27d ago, source: Nasdaq

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...

Jasper Therapeutics Stock (NASDAQ:JSPR), Analyst Ratings, Price Targets, Predictions

27d ago, source: Benzinga.com

$23.11-70.36% EF Hutton ...

Jasper Therapeutics Inc. Warrant

23d ago, source: TheStreet.com

This is not the Bentley for introverts. TheStreet’s automotive reporter got his hands on a Bentley Continental GT V8 S, and he shows off exactly what it can do.

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria

1mon ago, source: Nasdaq

REDWOOD CITY, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...

JSPR Jasper Therapeutics, Inc.

17d ago, source: Seeking Alpha

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company’s lead product ...

Jasper Therapeutics Inc Ordinary Shares

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...